Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.
about
The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretionPotential for developing purinergic drugs for gastrointestinal diseasesActivation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationExpression of Drosophila adenosine deaminase in immune cells during inflammatory response.Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.Adenosine negatively regulates duodenal motility in mice: role of A(1) and A(2A) receptors.Effect of Uncaria tomentosa extract on purinergic enzyme activities in lymphocytes of rats submitted to experimental adjuvant arthritis model.CD73 is critical for the resolution of murine colonic inflammationPurinergic receptors and gastrointestinal secretomotor function.Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients.Parasitic helminths: a pharmacopeia of anti-inflammatory molecules.Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.Protective effects of adenosine A2A receptor agonist in ventilator-induced lung injury in rats.Role of adenosine signaling in the pathogenesis of breast cancer.Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer.Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives.Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammationAdenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii.Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis.Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance.Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A1 Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility
P2860
Q24629948-E1531836-96E9-4BD1-992D-1512CDF85CDCQ27000719-458D19E4-97C3-4061-AA1E-28F33191D2C1Q33771708-A7E5A1FF-4F0A-4F9F-893E-F4E66733A2CCQ33830064-476CEF6C-D449-4B38-801A-181F8B7E2D81Q33848995-56D6ABFB-5BED-49B4-BADA-CDC3EF1D654DQ35048408-C2F41117-7D81-4128-9F8E-27E4C1959F32Q35593047-73BF3B34-9D8C-4C63-8EB1-F86A3EF45BB4Q35667893-D14C6B86-AFC2-4CC4-BFC7-DD5D00A07918Q36336800-F08B5CC4-9B87-4CB4-A022-D8C9B3A79B76Q36793761-3D3913B5-232A-4556-A74F-435FDAED7724Q36821572-F04B6C74-023F-4B97-95D0-483DD0AE92BDQ37044096-7D3A8A82-E539-4A1C-B82F-7E56E45DF89CQ37349951-B6AE8B26-EA24-4E81-BC72-4EFA1A28939AQ37635280-C7E3674C-B8A7-4DF2-A241-C3803773CCD4Q38262109-A0AA741A-CD72-4BB1-9BEE-F728C1D7749EQ39224357-E9EA8E11-B526-426A-8B32-517AB02C87DDQ39375802-E56D243F-F5F2-4743-B3EC-328FC260E1CEQ39404449-B041AFA3-CBA3-4D3D-A32C-1B17D2BEF6F1Q41474088-52AA3046-C246-430D-B9C0-5BB5B83D0702Q44175066-56BA723D-695D-4EF8-89B7-355F89C67230Q50108353-A835D643-5853-44DF-B07F-84BF1B7CC2F0Q55055302-D681E417-81DB-49FC-91EF-A5B9F8EE27A6Q58855712-71A7EE28-C06A-421F-91E1-B7EAFE1C63E5
P2860
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological modulation of ...... f inflammatory bowel diseases.
@en
Pharmacological modulation of ...... f inflammatory bowel diseases.
@nl
type
label
Pharmacological modulation of ...... f inflammatory bowel diseases.
@en
Pharmacological modulation of ...... f inflammatory bowel diseases.
@nl
prefLabel
Pharmacological modulation of ...... f inflammatory bowel diseases.
@en
Pharmacological modulation of ...... f inflammatory bowel diseases.
@nl
P2093
P2860
P921
P356
P1476
Pharmacological modulation of ...... f inflammatory bowel diseases.
@en
P2093
Corrado Blandizzi
Luca Antonioli
Marco Tuccori
Mario Del Tacca
Matteo Fornai
Narcisa Ghisu
Rocchina Colucci
P2860
P304
P356
10.1002/IBD.20316
P577
2008-04-01T00:00:00Z